Tag: stakeholder news & views
Urgent action needed to avoid widespread shortage of in-vitro diagnostic tests
![AdobeStock 135134857](/assets/Uploads/AdobeStock_135134857__ScaleMaxWidthWzY0MF0.jpeg)
In a new statement, BioMed Alliance highlights its increasing concern about the availability of In Vitro Diagnostic (IVD) testing devices in Europe.
More than science: the European Affairs program at EHA2023
![1800 20220610](/assets/Uploads/1800-20220610__ScaleMaxWidthWzY0MF0.jpg)
The ‘EU & Hematology track’ and other European Affairs activities at EHA2023 shed light on important regulatory developments and offer a platform for dialogue between hematologists, patients and other stakeholders.
Immunoglobulin shortages in the spotlight: EMA, SUPPLY and the SoHO Regulation
![SOHO EMA Image 1](/assets/Uploads/SOHO_EMA_Image-1__ScaleMaxWidthWzY0MF0.jpg)
EMA executive director Emer Cooke welcoming participants including EHA at the Shortages Workshop, March 1 Shortages of immunoglobulins and the need to increase and sustain plasma supplies have moved to the…
Call for urgent action on medicine shortages in Europe
![michal parzuchowski 7TWRwDjfGew unsplash](/assets/Uploads/michal-parzuchowski-7TWRwDjfGew-unsplash__ScaleMaxWidthWzY0MF0.jpg)
EPHA published a position paper on medicine shortages in Europe. EHA welcomes its recommendations to address the increasing shortages crisis, which threatens patient outcomes and patient safety.
EHA’s Prof Jäger elected HCPWP co-chair
![HCPWP co chairs Prof. Ulrich Jaeger EHA and Juan Garcia Burgos EMA](/assets/Uploads/HCPWP-co-chairs-Prof__ScaleMaxWidthWzY0MF0.-Ulrich-Jaeger-EHA-and-Juan-Garcia-Burgos-EMA.jpg)
On September 24, Prof Ulrich Jäger, former EHA President and current member of the EHA European Affairs Committee, was elected as co-chair of the Health Care Professionals Working Party (HCPWP) of the European Medicines Agency (EMA). He will lead the working party during its 2019-2022 mandate alongside Juan Garcia-Burgos, EMA’s head of Public Engagement.